PTC Therapeutics, Inc. (PTCT) earnings

  • Healthcare
  • NASDAQ
  • Market cap$4.7B

Next report

2027-02-18

In 88 daysQ4 FY2026AMC· Expected date
EPS consensus
0.35
-1.36 – 1.893 analysts
Revenue consensus
$330M

Latest result

24 days ago

⁦+16.8%⁩Revenue Beat

Estimate recorded after the release

2026-10-29Q3 FY2026AMC
EPS
Reported / estimate-0.62 / 0.14
Revenue
$358M / $306M

Stock reaction

⁦-6.97%⁩

⁦-5.19⁩ pts vs SPY

Session ⁦2026-10-30⁩

Recent quarters

Latest 3 quarters

Revenue and stock reaction

Reported / estimate

  • Q3 FY2026 · 2026-10-29-6.97%
    EPS-0.62 / 0.14-532.4%†
    Revenue$358M / $306M+16.8%
  • Q2 FY2026 · 2026-07-30-9.94%
    EPS0.92 / 0.24+289.3%†
    Revenue$361M / $299M+20.7%
  • Q1 FY2026 · 2026-05-07+14.27%
    EPS-0.03 / -0.45+93.3%†
    Revenue$273M / $217M+25.4%
  • †Unusually large: likely a one-off gain or charge, so not comparable with consensus
  • Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.